-+ 0.00%
-+ 0.00%
-+ 0.00%

Aprea Therapeutics Q1 EPS $(0.22) Beats $(0.23) Estimate

Benzinga·05/13/2026 10:36:51
Listen to the news
Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.23) by 4.35 percent. This is a 66.67 percent increase over losses of $(0.66) per share from the same period last year.